Bill
Bill > A5364
NJ A5364
NJ A5364Establishes program to subsidize purchase price of medical cannabis for registered qualifying patients enrolled in Medicaid or NJ Family Care programs.
summary
Introduced
02/23/2021
02/23/2021
In Committee
02/23/2021
02/23/2021
Crossed Over
Passed
Dead
01/11/2022
01/11/2022
Introduced Session
2020-2021 Regular Session
Bill Summary
This bill requires the Cannabis Regulatory Commission (CRC) to establish a program to subsidize up to 20 percent of the purchase price of medical cannabis and medical cannabis products dispensed to or on behalf registered qualifying patients who are currently enrolled in the State Medicaid program or the NJ FamilyCare program. The subsidy will reduce the purchase price of the medical cannabis or medical cannabis product as listed on the medical cannabis dispensary's or clinical registrant's website, and will be applied after any other discounts or price reductions are applied. The price reduction will apply at the point of purchase. The program developed by the CRC will include a mechanism for medical cannabis dispensaries and clinical registrants to quickly verify whether a registered qualifying patient to whom or on behalf of whom medical cannabis or a medical cannabis product is being dispensed is currently enrolled in Medicaid or NJ FamilyCare. The CRC will be required to coordinate with the Division of Medical Assistance and Health Services in the Department of Human Services to develop this enrollment verification system. Medical cannabis dispensaries and clinical registrants are to make patients and their caregivers aware of the subsidy program through posted signage, and may provide additional notice of the program verbally, using written materials, or both, but are not to apply a subsidy or attempt to verify whether a patient is enrolled in Medicaid or NJ FamilyCare except at the request of a patient or the patient's designated or institutional caregiver. The CRC will additionally be required to establish a process for medical cannabis dispensaries to apply for and receive reimbursement from the CRC for the amount of any subsidies applied to the purchase price of medical cannabis and medical cannabis products under the bill. Reimbursements for the subsidies will be paid out of funds available through the "Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Fund" established pursuant to Assembly Bill No.21(2R) of 2020/2021, which passed both Houses on December 17, 2020, or other funds made available to the CRC for this purpose. The bill will take effect 90 days after the effective date of Assembly Bill No.21(2R) of 2020/2021.
AI Summary
This bill requires the Cannabis Regulatory Commission (CRC) to establish a program to subsidize up to 20% of the purchase price of medical cannabis and medical cannabis products dispensed to registered qualifying patients enrolled in the State Medicaid program or the NJ FamilyCare program. The subsidy will be applied at the point of purchase after any other discounts or price reductions. The CRC will develop a mechanism for medical cannabis dispensaries and clinical registrants to verify a patient's enrollment in Medicaid or NJ FamilyCare, and will coordinate with the Division of Medical Assistance and Health Services to create this enrollment verification system. The CRC will also establish a process for dispensaries to apply for and receive reimbursement from the CRC for the subsidies. The reimbursements will be paid out of the Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Fund or other available funds.
Committee Categories
Health and Social Services
Sponsors (2)
Last Action
Introduced, Referred to Assembly Health Committee (on 02/23/2021)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| BillText | https://www.njleg.state.nj.us/2020/Bills/A9999/5364_I1.HTM |
| Bill | https://www.njleg.state.nj.us/2020/Bills/A9999/5364_I1.PDF |
Loading...